Form 8-K - Current report:
SEC Accession No. 0001104659-23-075861
Filing Date
2023-06-28
Accepted
2023-06-28 16:54:41
Documents
13
Period of Report
2023-06-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319765d5_8k.htm   iXBRL 8-K 47009
  Complete submission text file 0001104659-23-075861.txt   285098

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pmgm-20230628.xsd EX-101.SCH 3996
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmgm-20230628_def.xml EX-101.DEF 27706
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmgm-20230628_lab.xml EX-101.LAB 39306
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmgm-20230628_pre.xml EX-101.PRE 26326
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2319765d5_8k_htm.xml XML 7169
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 231052933
SIC: 2834 Pharmaceutical Preparations